Novavax
NVAX
#5429
Rank
C$2.12 B
Marketcap
C$12.90
Share price
-3.89%
Change (1 day)
49.56%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of March 2026 : -C$0.21 Billion

According to Novavax's latest financial reports the company has -C$0.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-C$0.18 Billion-80.46%
2024-12-31$-C$0.9 Billion-5.86%
2023-12-31$-C$0.96 Billion10.52%
2022-12-31$-C$0.87 Billion91.98%
2021-12-31$-C$0.45 Billion-156.04%
2020-12-31$C$0.79 B-429.18%
2019-12-31$-C$0.25 Billion6.2%
2018-12-31$-C$0.23 Billion78.86%
2017-12-31$-C$0.13 Billion1616.12%
2016-12-31$-C$7.46 Million-101.84%
2015-12-31$C$0.40 B52.36%
2014-12-31$C$0.26 B23.17%
2013-12-31$C$0.21 B171.14%
2012-12-31$C$79.79 M45.67%
2011-12-31$C$54.77 M-7.2%
2010-12-31$C$59.02 M-19.8%
2009-12-31$C$73.6 M33.07%
2008-12-31$C$55.31 M-12.09%
2007-12-31$C$62.91 M-42.52%
2006-12-31$C$0.10 B89.33%
2005-12-31$C$57.8 M44.61%
2004-12-31$C$39.97 M-14.27%
2003-12-31$C$46.62 M265.68%
2002-12-31$C$12.75 M-70.89%
2001-12-31$C$43.79 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
C$55.01 B-26,990.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$127.77 B-62,550.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$66.97 B-32,832.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$32.61 B-16,038.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.12 B-1,139.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.64 B-415.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-C$0.4 Billion 94.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$10.14 M-104.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$0.79 Billion 282.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.82 B-502.38%๐Ÿ‡บ๐Ÿ‡ธ USA